Samarth Kulkarni - Net Worth and Insider Trading

Over the past 18 months, Samarth Kulkarni made 15 insider transaction in CRISPR Therapeutics AG (CRSP) with a net sale of 350,337. Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 5,860 shares made by James R. Kasinger , a net sale of 3,524 shares made by Raju Prasad ,

In summary, during the past 3 months, insiders sold 139,721 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 139,721 shares. During the past 18 months, 359,721 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 359,721 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Samarth Kulkarni made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .

In summary, during the past 3 months, insiders sold 21,690 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 21,690 shares. During the past 18 months, 282,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,728,847 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Samarth Kulkarni made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,604,453 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,596,666 shares were bought by its insiders, resulting in a net purchase of 5,571,666 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Samarth Kulkarni made no insider transaction in Centessa Pharmaceuticals PLC (CNTA). Other recent insider transactions involving Centessa Pharmaceuticals PLC (CNTA) include a net sale of 54,070 shares made by Antoine Yver , a net sale of 41,751 shares made by Harris Rotman , and a net sale of 51,160 shares made by Karen M. Anderson .

In summary, during the past 3 months, insiders sold 55,427 shares of Centessa Pharmaceuticals PLC (CNTA) in total and bought 0 shares, with a net sale of 55,427 shares. During the past 18 months, 154,981 shares of Centessa Pharmaceuticals PLC (CNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 154,981 shares.

Centessa Pharmaceuticals PLC (CNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.